Regenerative Medicine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ( Cell-Based Immunotherapy and Cell Therapy Products, Tissue-Engineered Products, Gene Therapy Products ); Application ( Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes ) and Geography

Report Code: TIPHE100001194 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Regenerative medicine refers to a branch of medicine that develops a new methods to repair, regrow and replace damaged or diseases cells, organs and tissues. The regenerative medicines also includes the generation and use of therapeutic stem cells, production of artificial organs, and tissue engineering. Stem cell injections, prolotherapy, cartilage regeneration, and platelet rich plasma (PRP) are some of the common examples of regenerative medicine treatments that are employed by the physicians.

MARKET SCOPE

The "Global Regenerative Medicine Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the regenerative medicine market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading regenerative medicine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on type, the global regenerative medicine market is segmented into cell-based immunotherapy and cell therapy products, tissue-engineered products and gene therapy products.
  • On the basis of application, the market is segmented musculoskeletal disorders, wound care, oncology, ocular disorders and diabetes.

MARKET DYNAMICS

Drivers

  • Considerable rise in the number of individuals opting for organ transplant.
  • Increase in the global healthcare expenditure.
  • Rising prevalence of genetic and chronic diseases.

Restraints

  • Unorganized healthcare sector in few developing countries

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The regenerative medicine market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the regenerative medicine market in these regions.

IMPACT OF COVID-19 ON REGENERATIVE MEDICINE MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the regenerative medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from regenerative medicine market are anticipated to lucrative growth opportunities in the future with the rising demand for regenerative medicine in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the regenerative medicine market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Integra LifeSciences Corporation
  • Gilead Sciences
  • Novartis
  • Vericel Corporation
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker Corporation
  • Spark Therapeutics
  • Medtronic

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Regenerative Medicine Market - By Type
1.3.2 Regenerative Medicine Market - By Application
1.3.3 Regenerative Medicine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. REGENERATIVE MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. REGENERATIVE MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. REGENERATIVE MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. REGENERATIVE MEDICINE - GLOBAL MARKET OVERVIEW
6.2. REGENERATIVE MEDICINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. REGENERATIVE MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CELL-BASED IMMUNOTHERAPY AND CELL THERAPY PRODUCTS
7.3.1. Overview
7.3.2. Cell-Based Immunotherapy and Cell Therapy Products Market Forecast and Analysis
7.3.3. Allogeneic Products Market
7.3.3.1. Overview
7.3.3.2. Allogeneic Products Market Forecast and Analysis
7.3.4. Autologous Products Market
7.3.4.1. Overview
7.3.4.2. Autologous Products Market Forecast and Analysis
7.4. TISSUE-ENGINEERED PRODUCTS
7.4.1. Overview
7.4.2. Tissue-Engineered Products Market Forecast and Analysis
7.5. GENE THERAPY PRODUCTS
7.5.1. Overview
7.5.2. Gene Therapy Products Market Forecast and Analysis
8. REGENERATIVE MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MUSCULOSKELETAL DISORDERS
8.3.1. Overview
8.3.2. Musculoskeletal Disorders Market Forecast and Analysis
8.4. WOUND CARE
8.4.1. Overview
8.4.2. Wound Care Market Forecast and Analysis
8.5. ONCOLOGY
8.5.1. Overview
8.5.2. Oncology Market Forecast and Analysis
8.6. OCULAR DISORDERS
8.6.1. Overview
8.6.2. Ocular Disorders Market Forecast and Analysis
8.7. DIABETES
8.7.1. Overview
8.7.2. Diabetes Market Forecast and Analysis
9. REGENERATIVE MEDICINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Regenerative Medicine Market Overview
9.1.2 North America Regenerative Medicine Market Forecasts and Analysis
9.1.3 North America Regenerative Medicine Market Forecasts and Analysis - By Type
9.1.4 North America Regenerative Medicine Market Forecasts and Analysis - By Application
9.1.5 North America Regenerative Medicine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Regenerative Medicine Market
9.1.5.1.1 United States Regenerative Medicine Market by Type
9.1.5.1.2 United States Regenerative Medicine Market by Application
9.1.5.2 Canada Regenerative Medicine Market
9.1.5.2.1 Canada Regenerative Medicine Market by Type
9.1.5.2.2 Canada Regenerative Medicine Market by Application
9.1.5.3 Mexico Regenerative Medicine Market
9.1.5.3.1 Mexico Regenerative Medicine Market by Type
9.1.5.3.2 Mexico Regenerative Medicine Market by Application
9.2. EUROPE
9.2.1 Europe Regenerative Medicine Market Overview
9.2.2 Europe Regenerative Medicine Market Forecasts and Analysis
9.2.3 Europe Regenerative Medicine Market Forecasts and Analysis - By Type
9.2.4 Europe Regenerative Medicine Market Forecasts and Analysis - By Application
9.2.5 Europe Regenerative Medicine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Regenerative Medicine Market
9.2.5.1.1 Germany Regenerative Medicine Market by Type
9.2.5.1.2 Germany Regenerative Medicine Market by Application
9.2.5.2 France Regenerative Medicine Market
9.2.5.2.1 France Regenerative Medicine Market by Type
9.2.5.2.2 France Regenerative Medicine Market by Application
9.2.5.3 Italy Regenerative Medicine Market
9.2.5.3.1 Italy Regenerative Medicine Market by Type
9.2.5.3.2 Italy Regenerative Medicine Market by Application
9.2.5.4 Spain Regenerative Medicine Market
9.2.5.4.1 Spain Regenerative Medicine Market by Type
9.2.5.4.2 Spain Regenerative Medicine Market by Application
9.2.5.5 United Kingdom Regenerative Medicine Market
9.2.5.5.1 United Kingdom Regenerative Medicine Market by Type
9.2.5.5.2 United Kingdom Regenerative Medicine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Regenerative Medicine Market Overview
9.3.2 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis
9.3.3 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Regenerative Medicine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Regenerative Medicine Market
9.3.5.1.1 Australia Regenerative Medicine Market by Type
9.3.5.1.2 Australia Regenerative Medicine Market by Application
9.3.5.2 China Regenerative Medicine Market
9.3.5.2.1 China Regenerative Medicine Market by Type
9.3.5.2.2 China Regenerative Medicine Market by Application
9.3.5.3 India Regenerative Medicine Market
9.3.5.3.1 India Regenerative Medicine Market by Type
9.3.5.3.2 India Regenerative Medicine Market by Application
9.3.5.4 Japan Regenerative Medicine Market
9.3.5.4.1 Japan Regenerative Medicine Market by Type
9.3.5.4.2 Japan Regenerative Medicine Market by Application
9.3.5.5 South Korea Regenerative Medicine Market
9.3.5.5.1 South Korea Regenerative Medicine Market by Type
9.3.5.5.2 South Korea Regenerative Medicine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Regenerative Medicine Market Overview
9.4.2 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis
9.4.3 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Regenerative Medicine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Regenerative Medicine Market
9.4.5.1.1 South Africa Regenerative Medicine Market by Type
9.4.5.1.2 South Africa Regenerative Medicine Market by Application
9.4.5.2 Saudi Arabia Regenerative Medicine Market
9.4.5.2.1 Saudi Arabia Regenerative Medicine Market by Type
9.4.5.2.2 Saudi Arabia Regenerative Medicine Market by Application
9.4.5.3 U.A.E Regenerative Medicine Market
9.4.5.3.1 U.A.E Regenerative Medicine Market by Type
9.4.5.3.2 U.A.E Regenerative Medicine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Regenerative Medicine Market Overview
9.5.2 South and Central America Regenerative Medicine Market Forecasts and Analysis
9.5.3 South and Central America Regenerative Medicine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Regenerative Medicine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Regenerative Medicine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Regenerative Medicine Market
9.5.5.1.1 Brazil Regenerative Medicine Market by Type
9.5.5.1.2 Brazil Regenerative Medicine Market by Application
9.5.5.2 Argentina Regenerative Medicine Market
9.5.5.2.1 Argentina Regenerative Medicine Market by Type
9.5.5.2.2 Argentina Regenerative Medicine Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL REGENERATIVE MEDICINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. REGENERATIVE MEDICINE MARKET, KEY COMPANY PROFILES
12.1. INTEGRA LIFESCIENCES CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GILEAD SCIENCES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. VERICEL CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. WRIGHT MEDICAL
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MIMEDX
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. OSIRIS THERAPEUTICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. STRYKER CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SPARK THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MEDTRONIC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

 

The List of Companies

1. Integra LifeSciences Corporation
2. Gilead Sciences
3. Novartis
4. Vericel Corporation
5. Wright Medical
6. MiMedx
7. Osiris Therapeutics
8. Stryker Corporation
9. Spark Therapeutics
10. Medtronic
11. 3M
12. Allergan Plc
13. Aspect Biosystems
14. Bluebird Bio
15. Amgen, Inc.
16. Smith and Nephew Plc
17. Corestem, Inc.
18. Organogenesis
19. Kite Pharma
20. Spark Therapeutics

 

TIPHE100001194
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking